Notice of Meeting and Proxy Form

Notice is given that the annual meeting of shareholders
of EBOS Group Limited (the Company) (Annual Meeting)
will be held at Addington Raceway & Events Centre,
75 Jack Hinton Drive, Christchurch on 19 October 2021,
and online virtually through the Computershare Meeting
Services web platform https://meetnow.global/nz,
commencing at 2.00pm.
Covid-19 Implications
The Company is closely monitoring restrictions in New
Zealand as a result of the COVID-19 pandemic. Having
regard to the health and safety of our stakeholders and
people, if the alert level is expected to be above Level 1
in any region of New Zealand on the date of the Annual
Meeting, the Company may elect to hold this Annual
Meeting as an online only meeting. In such circumstances,
the Company will provide shareholders with as much
notice as is reasonably practicable by way of an
announcement to the NZX and ASX and on the Company’s
website including providing details of how to participate in
an online meeting.
General Business
1 To consider and receive the annual report and the
financial statements for the year ended 30 June 2021
and the audit report thereon.
To consider and if thought fit, pass the following
ordinary resolutions 1 to 5:
2 Resolution 1 – Election of Director
It is hereby resolved that Tracey Batten be elected
as a director of the Company.
3 Resolution 2 – Re-election of Director
It is hereby resolved that Elizabeth Coutts be re-elected
as a director of the Company.
4 Resolution 3 – Re-election of Director
It is hereby resolved that Peter Williams be re-elected
as a director of the Company.
5 Resolution 4 - Non-executive director remuneration
It is hereby resolved that, pursuant to NZX Listing Rule
2.11.1 and ASX Listing Rule 10.17, the total remuneration
for non-executive directors be increased by $155,000
from $1,410,000 per annum to $1,565,000 per annum
with effect from 1 July 2021.
6 Resolution 5 - Auditor’s remuneration
It is hereby resolved that the directors of the Company
be authorised to fix the fees and expenses of Deloitte
as auditor of the Company.
7 To consider any other business that can be properly
brought before the meeting.
Please see explanatory notes for further information
regarding Resolutions 1 to 5.
By Order of the Board
Elizabeth Coutts
Chair
Christchurch, New Zealand
16 September 2021
Explanatory Notes
Resolution 1
Election of Director – Tracey Batten
Dr Batten (MBBS, MHA, FRACMA, MBA, FAICD) was
appointed as a director by the Board to fill a casual
vacancy effective 1 July 2021.
Dr Batten is currently a non-executive director of
Medibank Private Limited, the Accident Compensation
Corporation and the National Institute of Water and
Atmospheric Research. She was previously a
non-executive director of Abano Healthcare Group Limited
and various other healthcare related research institutes,
charities and industry and government bodies.
During her executive career Dr Batten was Group CEO
of Imperial College Healthcare NHS Trust in the United
Kingdom, Group CEO of St Vincent’s Health Australia,
CEO of Eastern Health and CEO of Dental Health Services
Victoria.
The Board considers Tracey Batten is an Independent
Director as referred to in the NZX Listing Rules.
Pursuant to NZX Listing Rule 2.7.1 and ASX Listing Rule
14.4, a director appointed by the Board must not hold
office (without re-election) past the next annual meeting
following the Director’s appointment.
Dr Batten retires in accordance with NZX Listing Rule 2.7.1
and ASX Listing Rule 14.4, and offers herself for election.
Notice of Annual
Meeting 2021

Resolution 2
Re-election of Director – Elizabeth Coutts
Ms Coutts (ONZM, BMS, FCA) was appointed as a
director on 3 July 2003. She is Chair of the Remuneration
Committee and a member of the Audit and Risk
Committee.
Ms Coutts is also currently Chair of Oceania Healthcare
Limited and Skellerup Holdings Limited, Director of EBOS
Group subsidiaries in New Zealand and Member, Marsh
New Zealand Advisory Board.
She is a former Chair of Ports of Auckland Limited,
Meritec Group, Industrial Research, Life Pharmacy
Limited and former Deputy Chair of Public Trust. She has
previously held directorships of Air New Zealand Limited,
the Health Funding Authority, Sanford Limited and the
Yellow Group of Companies.
She is also a former board member of Sport NZ, former
board member of Tennis Auckland Region Incorporated,
former member of the Pharmaceutical Management
Agency (Pharmac), former Commissioner for both the
Commerce and Earthquake Commissions, former external
monetary policy adviser to the Governor of the Reserve
Bank of New Zealand, a former President of the Institute
of Directors Inc and former Chief Executive of the Caxton
Group of Companies.
The Board considers Elizabeth Coutts is an Independent
Director as referred to in the NZX Listing Rules.
Pursuant to NZX Listing Rule 2.7.1 and ASX Listing Rule 14.4,
a director must not hold office without re-election past the
third annual meeting following the director’s appointment,
or 3 years, whichever is longer.
Ms Coutts retires in accordance with NZX Listing Rule 2.7.1
and ASX Listing Rule 14.4, and offers herself for re-election.
Resolution 3
Re-election of Director – Peter Williams
Mr Williams was appointed as a director on 5 July 2013.
Mr Williams is also a director of Green Cross Health
Limited. He was formerly an executive of The Zuellig Group
and has extensive experience in the healthcare industry in
Australasia and Asia.
The Board considers Peter Williams is an Independent
Director as referred to in the NZX Listing Rules.
Pursuant to NZX Listing Rule 2.7.1 and ASX Listing Rule 14.4,
a director must not hold office without re-election past the
third annual meeting following the director’s appointment,
or 3 years, whichever is longer.
Mr Williams retires in accordance with NZX Listing Rule 2.7.1
and ASX Listing Rule 14.4, and offers himself for re-election.
Resolution 4
Non-executive director remuneration
This resolution is put to shareholders in accordance with
NZX Listing Rule 2.11.1 and ASX Listing Rule 10.17 and relates
to the maximum aggregate fees payable to all non-
executive directors. ASX Listing Rule 10.17 provides that the
Company must not increase the total aggregate amount
of ‘directors’ fees’ (as defined in that Listing Rule) payable
to all of its non-executive directors without the approval of
holders of ordinary shares.
At present the maximum fee pool for non-executive
directors is $1,410,000 per annum, as approved by
shareholders at the Company’s annual meeting on 15
October 2019. It is proposed to increase this amount by
$155,000 to $1,565,000 per annum, being an 11% increase.
During 2021, an independent benchmarking report
was commissioned by the Board from KPMG Australia
(Independent Report). The changes proposed by the
Board have regard to the current market positioning of
EBOS’ fees and align with the commentary outlined in the
Independent Report (further explanations below).
The increase proposed is broken down as follows:
• a $16,000 or 5% increase to the Chair fee and a $8,000
or 5% increase to the director fee (within the percentage
range noted in the Independent Report);
• increases to Board committee (Committee) fees to
position them at, or about, the median of the market data
outlined in the Independent Report, per the following
amounts and percentages:
> a $2,500 or 6.7% increase to the Chair of Audit & Risk
Committee fee;
> a $2,500 or 14.3% increase for Member of Audit & Risk
Committee fees;
> a $13,000 or 65% increase to the Chair of Remuneration
Committee fee;
> a $6,500 or 65% increase for Member of Remuneration
Committee fees; and
• an additional $75,000 pool available for special
exertion fees, payable for project work undertaken by
directors outside of the normal workload for the Board
and Committees. This proposed pool was noted in the
Independent Report as “reasonable, provided there is
clear disclosure to investors of the pool and how it is
used”.
The Company is seeking the approval of shareholders
to increase the maximum fee pool for non-executive
directors for the following reasons:
Notice of Annual
Meeting 2021

Notice of Annual
Meeting 2021
• the increasing workload and time commitment of the
Company’s directors. The Company has experienced
significant growth and robust financial performance
since the director fee pool was last approved by
shareholders in 2019. In FY2021, EBOS recorded revenue
of A$9.2 billion and NPAT of A$185.3 million, which is 33%
and 35% higher respectively than recorded in FY2019.
In addition, EBOS’ total shareholder return over the
period 30 June 2019 to 30 June 2021 was 47%
1
.
The Company’s operations continue to grow in size and
complexity, with EBOS operating across two jurisdictions:
Australia and New Zealand. With the majority of the
Company’s business taking place in Australia, the
Board has additional complexities in carrying out its
functions. Continued increase in legislative compliance
requirements for the Company, as well the factors
described above have led to an increase in workload for
directors, including the workload of those directors that
are appointed to Committees. This is demonstrated by
the number of meetings attended by Board members
doubling from six meetings in FY2019 to twelve in FY2021.
The number of Board and Committee meetings attended
by each director is set out in the Director’s Interests and
Disclosures section of the Company’s Annual Report,
noting that in FY2021 all then-current directors attended
each Board meeting and Committee meeting
(where that director was a member of a Committee);
• the current market positioning of EBOS’ fees.
The Company seeks to remunerate non-executive
directors at market-competitive rates to support the
attraction and retention of directors of the highest
calibre and requisite expertise. The Independent Report
identified that fees paid to members of the EBOS
Remuneration Committee in particular were significantly
lower than the median for the market. Therefore the
Board considers that the increase is appropriate; and
• to ensure that the aggregate remuneration can
accommodate payment of fees to non-executive
directors for additional duties, should this be required.
This would be funded through the proposed special
exertion fee pool, paid out for significant project work
undertaken by directors outside of the normal workload
for the Board and Committees. Any fees paid out of this
special exertion fee pool would be clearly reported each
year (including the rationale for all payments out of this
special exertion fee pool).
The Board considers, in light of the market data outlined in
the Independent Report and the realities of the increased
workloads undertaken by the Board, that the proposed
increased fee pool is fair and reflective of market
conditions.
The table below sets out the director and Committee fees
expressed on a per annum basis as at 30 June 2021, the
expected fee allocations should the increase in the fee pool
be approved, and the amount of the increase proposed.
1
Total shareholder return comprises the increase in EBOS’ share price from 30 June 2019 to 30 June 2021 as well as total
dividends declared in respect of FY2020 and FY2021.
Officer30 June 2021Post shareholder
approval
Amount of increase
Chair$320,000$336,000$16,000
Director (other than Chair)$160,000$168,000$8,000
Chair of Audit & Risk Committee$37,500$40,000$2,500
Chair of Remuneration Committee$20,000$33,000$13,000
Member of Audit & Risk Committee $17,500$20,000$2,500
Member of Remuneration Committee$10,000$16,500$6,500
Special Exertion fee pool$0$75,000New pool
All amounts expressed in New Zealand dollars.
The amounts are inclusive of superannuation contributions (if applicable).

Notice of Annual
Meeting 2021
Independent benchmarking process
As noted above, the Board is committed to setting director
fees in a transparent manner. Accordingly, it appointed
KPMG Australia to prepare the Independent Report
(see: https://ebosgroup.gcs-web.com/2021-annual-
meeting).
In summary, KPMG found:
• EBOS’ fee pool is positioned at the lower 28th percentile
of the comparator group used in the Independent Report.
KPMG commented that the Board may wish to consider
seeking shareholder approval to increase EBOS’ fee pool
in order to accommodate any fee increases in the short
to medium term;
• EBOS’ Board Chair and base member fees are positioned
around the median of the comparator group. KPMG
commented that a modest increase of between 3% to 5%
to these fees appeared reasonable;
• EBOS’ Audit & Risk Committee Chair and member fees
are positioned around the median of the comparator
group; and
• EBOS’ Remuneration Committee Chair and member
fees are positioned in the bottom quartile of the
comparator group. KPMG commented that there may be
an opportunity to revisit the fees for this Committee to
position them closer to the median.
Board succession planning
In considering the nominations of both Elizabeth Coutts
and Peter Williams for re-election, the Board determined
that, notwithstanding their tenure, they both continue to
have vital skills (as identified in the Director’s skills matrix)
and significant institutional knowledge which cannot be
replicated by other candidates at this stage of the Board’s
succession planning.
The succession planning process remains a focus of
the Board given there are directors with long tenures at
the Company who have indicated an intention to retire
over the next few years. As succession takes place, it
is the Board’s view that a smooth transition process is
essential to the effective governance of the Company
and, accordingly, additional directors may need to be
appointed prior to current directors retiring.
The Company will need to offer competitive fees to attract
and retain non-executive directors of a high calibre from
New Zealand, Australia and internationally. The Directors’
skills matrix is set out at the Company’s website and in
its 2021 Corporate Governance Statement (see: https://
ebosgroup.gcs-web.com/corporate-governance).
Over the next year, the Board will continue to consider the
additional skills that would be beneficial to the Company
as well as preparing for Board succession. COVID-19
restrictions continue to impact the Board’s deliberations
on these matters as the imposition of lockdowns across
New Zealand and Australia makes the task of meeting
suitable candidates in person more difficult. As a result,
succession planning is expected to take some time as
the Board is mindful of providing stability and a cohesive
culture, which has underpinned EBOS’ success to date.
Listing Rules notes
No securities have been issued to any non-executive
director under ASX Listing Rules 10.11 or 10.14 with
shareholder approval within the last three years. If the
resolution is not passed then the non-executive director
fee pool will remain $1,410,000 per annum.
Under NZX Listing Rule 6.3.1, the non-executive directors
(being all of the current directors of the Company) and
their Associated Persons (as that term is defined in the
NZX Listing Rules) are precluded from voting in respect
of this Resolution. This does not however prevent a
non-executive director who has been appointed as a
proxy or a voting representative by another person who
is not disqualified from voting, or an Associated Person
of a non-executive director, from voting in respect of the
shares held by that other person in accordance with the
express instructions of that other person.
In addition, in accordance with the ASX Listing Rules,
the Company will disregard any votes cast in favour of
Resolution 4 by or on behalf of: (i) the directors; and (ii)
an associate (as that term is defined in the ASX Listing
Rules) of any of the directors. However this does not apply
to a vote cast in favour of Resolution 4 by: (i) a person as
a proxy or attorney for a person who is entitled to vote
on the resolution, in accordance with the directions given
to the proxy or attorney to vote on the resolution in that
way; (ii) the Chair as proxy or attorney for a person who
is entitled to vote on the resolution, in accordance with
a direction given to the Chair to vote on the resolution
as the Chair decides; or (iii) a holder acting solely in a
nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions
are met: (A) the beneficiary provides written confirmation
to the holder that the beneficiary is not excluded from
voting, and is not an associate of a person excluded from
voting, on the resolution; and (B) the holder votes on the
resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.

Notice of Annual
Meeting 2021
Resolution 5
Auditor’s remuneration
As set out in the Company’s Corporate Governance Code
the auditor’s lead and engagement audit partners should
be rotated after a maximum of five years. In addition,
under the Company’s Audit & Risk Committee Charter,
the Committee is responsible for addressing what, if any,
services other than audit services may be provided by the
auditors. The Company’s Corporate Governance Code
and Audit & Risk Committee Charter can be found at
https://ebosgroup.gcs-web.com/corporate-governance.
Deloitte is automatically reappointed as the auditor of
the Company under section 207T of the Companies Act
1993. Pursuant to section 207S of the Companies Act 1993,
this resolution authorises the directors to fix the fees and
expenses of the auditor.
Attendance
The Company is holding a hybrid annual meeting this
year to allow shareholders who are unable to attend
in person the opportunity to attend online through the
Computershare Meeting Services web platform. Due to
the uncertainty of New Zealand Alert Level changes,
the Company has decided to move away from a webcast
option (previously used alongside the physical meeting)
to an interactive, fully hybrid annual meeting.
Shareholders joining the hybrid meeting virtually will be
able to view the presentations, vote on the resolutions
to be put to shareholders and ask questions, by using
their own computers or mobile devices. Shareholders will
still be able to appoint a proxy to vote for them as they
otherwise would, by following the instructions on the
proxy form and this Notice of Annual Meeting. Details
of how to participate ‘virtually’ are provided in the
accompanying Virtual Meeting Guide, with instructions
for accessing the virtual meeting.
All shareholders are entitled to attend and (subject to the
exception set out below) vote at the meeting or to appoint
a proxy, attorney or representative (in the case of a
corporate shareholder) to attend and vote on their behalf
(in person or via the web platform).
Except as set out in the NZX Listing Rules, the ASX Listing
Rules and the Company’s constitution, there are no voting
restrictions which prevent any shareholder from voting on
any of the resolutions.
Having regard to the New Zealand and/or Australian
travel restrictions in place at the time of the Annual
Meeting, shareholders are advised that some directors
and senior management of the Company may attend the
hybrid meeting by audio or video means, rather than in
person in Christchurch. This is likely to include the Chief
Executive Officer.
As noted above, the Company is closely monitoring
restrictions in New Zealand as a result of the COVID-19
pandemic, and may elect to hold this Annual Meeting
as an online only meeting. In such circumstances, the
Company will provide shareholders with as much notice as
is reasonably practicable by way of an announcement to
the NZX and ASX and on the Company’s website including
providing details of how to participate in an online
meeting.
Voting
Voting on all resolutions put before this Annual Meeting
will be by poll. Results of voting will be available after the
conclusion of the Annual Meeting, and will be notified on
NZX and ASX.
Proxies
A proxy form is enclosed with this notice.
If you do not plan to attend the Annual Meeting, you may
appoint a proxy. The Chair of the Annual Meeting is willing
to act as a proxy for any shareholder who appoints that
person for that purpose. To do this, enter “the Chair” or
the name of your proxy in the space allocated in “Step
1” of the enclosed form. Alternatively you can appoint a
proxy online at www.investorvote.co.nz. Please note that if
you appoint a proxy to cast your vote, you are still able to
attend the Annual Meeting online, however, you will not be
able to cast your votes held by your proxy.
If in appointing your proxy, you do not name a person as
your proxy (either online or on the proxy form), or your
named proxy does not attend the meeting, the Chair of
the Annual Meeting will be your proxy and may vote only in
accordance with your express direction. ASX Listing Rule
14.2.2 requires the Company to state how the Chair will
vote undirected (discretionary) proxies. The Chair will vote
all undirected proxies in favour of the resolutions.
Any decision by the Company to move this Annual Meeting
to an online only meeting will not affect any proxies validly
appointed before any such change.

How to Vote on Items of Business
All your securities will be voted in accordance with your directions.
Hybrid meeting
The hybrid meeting will be accessible on both desktop and mobile devices. Please
refer to the Virtual Meeting Guide that accompanies the Notice of Meeting. If you
appoint a proxy to cast your vote, you are still able to attend the Annual Meeting via
the web platform, however, you will not be able to cast your votes held by your proxy.
Appointment of Proxy
If you do not plan to attend the meeting, you may appoint a proxy. The Chairman of
the meeting is willing to act as a proxy for any shareholder who appoints him or her
for that purpose. To do this, enter ‘the Chairman’ or the name of your proxy in the
space allocated in ‘Step 1’of this form. Alternatively you can appoint a proxy online at
www.investorvote.co.nz.
If in appointing your proxy, you do not name a person as your proxy (either online or
on this proxy form), or your named proxy does not attend the meeting, the Chairman
of the meeting will be your proxy and may vote only in accordance with your express
direction. ASX Listing Rule 14.2.2 requires the Company to state how the Chairman
will vote undirected proxies. The Chairman will vote all undirected proxies in favour of
the resolutions.
Voting of your Holding
Direct your proxy how to vote by marking one of the boxes opposite each item of business.
If you do not mark a box your proxy may vote as they choose. If you mark more than one
box on an item your vote will be invalid on that item.
Attending the Meeting
Bring this form to assist registration. If a representative of a corporate securityholder or
proxy is to attend the meeting you will need to provide the appropriate “Certificate of
Appointment of Corporate Representative” prior to admission.
Signing Instructions for Postal Forms
Individual
Where the holding is in one name, the securityholder must sign.
Joint Holding
Where the holding is in more than one name, all of the securityholders should sign.
Power of Attorney
If this Proxy Form has been signed under a power of attorney, a copy of the power of
attorney (unless already deposited with the Company) and a signed certificate of
non-revocation of the power of attorney must be produced with this Proxy Form.
Companies
This form must be signed by a Director jointly with another Director, or a Sole Director can
sign alone. Please sign in the appropriate place and indicate the office held.
Comments, questions and amendments
If you have any comments or questions for the Company, please write them on a separate
sheet of paper and return with this form. Please note that no amendments to resolutions
proposed or resolutions from the floor will be accepted.
Go online to lodge your proxy or turn over to complete the form
The Company is closely monitoring restrictions in New Zealand as a result of the COVID-19 pandemic. Having regard to the health and safety
of our stakeholders and people, if the alert level is expected to be above Level 1 in any region of New Zealand on the date of the Annual
Meeting, the Company may elect to hold this Annual Meeting as an online only meeting. In such circumstances, the Company will provide
shareholders with as much notice as is reasonably practicable by way of an announcement to the NZX and ASX and on the Company’s
website including providing details of how to participate in an online meeting.
COVID-19 IMPLICATIONS
Lodge your proxy
Online
www.investorvote.co.nz
By Mail
Computershare Investor Services Limited
Private Bag 92119, Auckland 1142, New Zealand
By Fax
+64 9 488 8787
For all enquiries contact
+64 9 488 8777
corporateactions@computershare.co.nz
Your secure access information
Control Number: CSN/Securityholder Number:
PLEASE NOTE: You will need your CSN/Securityholder Number and postcode or country of residence (if outside New Zealand) to
securely access InvestorVote and then follow the prompts to appoint your proxy and exercise your vote online.
Proxy/Voting Form
Lodge your proxy online, 24 hours a day, 7 days a week:
www.investorvote.co.nz
Scan the QR code to vote now.
Smartphone?
For your proxy to be effective it must be received by 2:00pm Sunday 17 October 2021

Proxy/Corporate Representative Form
Appoint a Proxy to Vote on Your Behalf
STEP 1
hereby appoint of
or failing him/herof
as my/our proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions at the Annual Meeting of Shareholders of
EBOS Group Limited to be held at the Addington Raceway & Events Centre, 75 Jack Hinton Drive, Christchurch and online virtually through the Computershare
Meeting Services web platform on Tuesday, 19 October 2021 at 2:00pm and at any adjournment of that meeting.
I/We being a shareholder/s of EBOS Group Limited
Appoint a Proxy to Vote on Your Behalf
STEP 1
Proxy
Discretion
Items of Business - Voting Instructions/Ballot Paper
STEP 2
Please note: If you mark the Abstain box for an item, you are directing your proxy not to vote on your behalf and your votes will not be counted in
computing the required majority.
or failing him/her, or if no person is named, the Chairman of the meeting
Ordinary Resolution
1.
It is hereby resolved that Tracey Batten be elected as a director of the Company.
2.
It is hereby resolved that Elizabeth Coutts be re-elected as a director of the Company.
3.
It is hereby resolved that Peter Williams be re-elected as a director of the Company.
4.
It is hereby resolved that, pursuant to NZX Listing Rule 2.11.1 and ASX Listing Rule 10.17, the total remuneration
for non-executive directors be increased by $155,000 from $1,410,000 per annum to $1,565,000 per annum
with effect from 1 July 2021.
5.
It is hereby resolved that the directors of the Company be authorised to fix the fees and expenses of Deloitte as
auditor of the Company.
For
Against
Abstain
ATTENDANCE SLIP
Annual Meeting of Shareholders of EBOS Group Limited to be
held at the Addington Raceway & Events Centre, 75 Jack Hinton
Drive, Christchurch and online virtually through the Computershare
Meeting Services web platform on Tuesday, 19 October 2021
at 2:00pm.
Signature of Securityholder(s) This section must be completed.
SIGN
or Sole Director/Directoror Director (if more than one)
Securityholder 1Securityholder 2 Securityholder 3
Contact Name Contact Daytime Telephone Date
If your proxy is not the Chair of the Meeting or any other director of the Company, please ensure that you provide their contact details (phone and email
address). If this information is not provided, we cannot guarantee remote admission to the virtual meeting for your proxy.
Proxy contact Details (Phone): and (Email):

Attending the meeting online
Our online meeting provides you the opportunity to
participate online using your smartphone, tablet or computer.
If you choose to attend online you will be able to view a live
webcast of the meeting, ask questions and submit your
votes in real time.
You will need the latest v
ersion of Chrome, Safari,
Edge or F irefox. Please ensure your browser is
compatible.
HOW TO PARTICIPATE IN VIRTUAL/HYBRID MEETINGS
Visit https://meetnow.global/nz
When successfully authenticated, the home screen
will be displayed. You can watch the webcast, vote,
ask questions, and view meeting materials in the
documents folder. The image highlighted blue
indicates the page you have active.
The webcast will appear and begin automatically
once the meeting has started.
Voting
Resolutions will be put forward once voting is
declared open by the Chair. Once the voting has
opened, the resolution and voting options will appear.
To vote, simply select your voting direction from the
options shown on screen. You can vote for all
resolutions at once or by each resolution.
Your vote has been cast when the green tick appears.
To change your vote, select ‘Change Your Vote’.
Q&A
Any eligible shareholder/proxy attending the meeting
r
emotely is eligible to ask a question.
S
elect the Q&A tab and type your question into the
box at the bottom of the screen and press 'Send'.
Navigation
Access
Access the online meeting at
https://meetnow.global/nz, and select the required
meeting. Click 'JOIN MEETING NOW'.
If you are a shareholder:
Select 'Shareholder' on the login screen and enter
your CSN/Holder Number and Post Code. If you are
outside New Zealand, simply select your country
from the drop down box instead of the post code.
Accept the Terms and Conditions and click Continue.
If you are a guest:
Select Guest on the login screen. As a guest, you will
be prompted to complete all the relevant fields
including title, first name, last name and email
address.
Please note, guests will not be able to ask questions
or vote at the meeting.
If you are a proxy holder:
You will receive an email invitation the day before the
meeting to access the online meeting. Click on the
link in the invitation to access the meeting.
Contact
If you have any issues accessing the website please
c
all +64 9 488 8700.